Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Healthtrust
Daiichi Sankyo
Dow
US Army
Chubb
McKinsey
Johnson and Johnson
Federal Trade Commission
Express Scripts

Generated: February 23, 2018

DrugPatentWatch Database Preview

HYDROXOCOBALAMIN Drug Profile

« Back to Dashboard

Which patents cover Hydroxocobalamin, and when can generic versions of Hydroxocobalamin launch?

Hydroxocobalamin is a drug marketed by Abraxis Pharm, Actavis Llc, and Watson Labs. and is included in three NDAs.

The generic ingredient in HYDROXOCOBALAMIN is hydroxocobalamin. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxocobalamin profile page.
Drug patent expirations by year for HYDROXOCOBALAMIN
Pharmacology for HYDROXOCOBALAMIN
Drug ClassAntidote
Medical Subject Heading (MeSH) Categories for HYDROXOCOBALAMIN

US Patents and Regulatory Information for HYDROXOCOBALAMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm HYDROXOCOBALAMIN hydroxocobalamin INJECTABLE;INJECTION 084921-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Llc HYDROXOCOBALAMIN hydroxocobalamin INJECTABLE;INJECTION 085998-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs HYDROXOCOBALAMIN hydroxocobalamin INJECTABLE;INJECTION 085528-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Citi
Moodys
US Department of Justice
Merck
US Army
AstraZeneca
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot